IL90058A0 - Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies - Google Patents

Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies

Info

Publication number
IL90058A0
IL90058A0 IL90058A IL9005889A IL90058A0 IL 90058 A0 IL90058 A0 IL 90058A0 IL 90058 A IL90058 A IL 90058A IL 9005889 A IL9005889 A IL 9005889A IL 90058 A0 IL90058 A0 IL 90058A0
Authority
IL
Israel
Prior art keywords
peptide
pharmaceutical compositions
directed against
hiv envelope
monoclonal antibodies
Prior art date
Application number
IL90058A
Other languages
English (en)
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/324,027 external-priority patent/US5562905A/en
Application filed by Du Pont filed Critical Du Pont
Publication of IL90058A0 publication Critical patent/IL90058A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL90058A 1988-04-26 1989-04-24 Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies IL90058A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18633388A 1988-04-26 1988-04-26
US07/324,027 US5562905A (en) 1988-04-26 1989-03-20 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Publications (1)

Publication Number Publication Date
IL90058A0 true IL90058A0 (en) 1989-12-15

Family

ID=26881983

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90058A IL90058A0 (en) 1988-04-26 1989-04-24 Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies

Country Status (10)

Country Link
EP (1) EP0339504A3 (xx)
JP (1) JPH02160800A (xx)
AU (1) AU632475B2 (xx)
DK (1) DK200189A (xx)
FI (1) FI891957A (xx)
HU (1) HUT51296A (xx)
IL (1) IL90058A0 (xx)
NO (1) NO891711L (xx)
NZ (1) NZ228869A (xx)
PT (1) PT90376B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0768276B2 (ja) * 1989-04-25 1995-07-26 タノックス バイオシステムズ インコーポレイテッド Ｈｉｖのｃｄ４結合領域に特異的な抗体
JPH05506561A (ja) * 1989-06-05 1993-09-30 レプリゲン・コーポレーション ＨＩＶ―１　ＭＮ　ｇｐ１２０のヒトモノクローナル抗体
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
EP0527760B1 (en) * 1990-04-03 1995-07-19 Genentech, Inc. Methods and compositions for vaccination against hiv
AU8007991A (en) * 1990-06-29 1992-01-23 Daniel Zagury Methods of inducing immune response to aids virus
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
WO1992021377A1 (en) * 1991-06-03 1992-12-10 Syntello Inc. Peptides for use in induction of t cell activation against hiv-1
US5558865A (en) * 1991-08-22 1996-09-24 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
RU2128222C1 (ru) * 1991-08-22 1999-03-27 Ниссин Сокухин Кабусики Кайся Мышиное моноклональное антитело nm01, гибридомная клеточная линия, фрагмент мышиного могоклонального антитела (варианты)
ATE190226T1 (de) * 1991-12-02 2000-03-15 Univ Texas Zusammensetzungen zum auslösen cytotoxischer t- lymphozyten gegen viren
IL103928A0 (en) * 1991-12-11 1993-04-04 American Home Prod Expression of specific immunogens using viral antigens
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
WO1993019775A1 (en) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
AU5359094A (en) * 1992-10-13 1994-05-09 Children's Hospital Oral tolerance and immune suppression in the treatment of aids
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DE69433422T2 (de) * 1993-03-11 2004-09-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Monoklonaler anti-hiv antikörper
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
US5864027A (en) * 1993-06-07 1999-01-26 Genentech, Inc. HIV envelope polypeptides
JPH09506428A (ja) * 1993-10-15 1997-06-24 エム． ラコウィック−ズルチェンスカー，エバ 乳癌および婦人科の癌の検出および治療
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
FR2874612A1 (fr) * 2004-08-27 2006-03-03 Commissariat Energie Atomique Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571968B1 (fr) * 1984-10-18 1989-03-17 Pasteur Institut Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE3588248T2 (de) * 1984-10-18 2004-07-01 Institut Pasteur LAV-Antigene und -Peptide
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
WO1988009181A2 (en) * 1987-05-29 1988-12-01 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
EP0400076B1 (en) * 1988-01-26 1996-05-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A synthetic antigen evoking anti-hiv response

Also Published As

Publication number Publication date
EP0339504A2 (en) 1989-11-02
FI891957A (fi) 1989-10-27
DK200189A (da) 1989-10-27
NO891711D0 (no) 1989-04-25
AU3332089A (en) 1989-11-02
NO891711L (no) 1989-10-27
FI891957A0 (fi) 1989-04-25
EP0339504A3 (en) 1990-09-12
JPH02160800A (ja) 1990-06-20
NZ228869A (en) 1992-02-25
AU632475B2 (en) 1993-01-07
PT90376B (pt) 1995-01-31
HUT51296A (en) 1990-04-28
PT90376A (pt) 1989-11-10
DK200189D0 (da) 1989-04-25

Similar Documents

Publication Publication Date Title
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ230199A (en) Antibody drug conjugate, intermediates and pharmaceutical compositions
IL106600A (en) Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
EP0570916A3 (en) Serum albumin, recombinant human, preparation process and pharmaceutical composition.
PH31059A (en) Pharmaceutical compositions comprising cyclosporins.
NZ213566A (en) Grf releasing peptides, and pharmaceutical compositions
NZ222981A (en) 2'-deoxy-2'2'-difluoronucleosides, antibody conjugates and pharmaceuticals containing the conjugates
IL98845A0 (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
IL89778A (en) Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them
IL85885A0 (en) Cyclic peptides,their preparation and pharmaceutical compositions containing them
IL98769A (en) Synthetic peptides, mixtures thereof, methods utilizing the same for detecting hiv antibodies and pharmaceutical compositions containing the same
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL85688A0 (en) Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
IL86710A0 (en) Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same
IL96216A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
IL91402A0 (en) Aminomethyl peptides,their preparation and pharmaceutical compositions containing them
DE3264718D1 (en) Piperazinoquinazoline antihypertensives, processes for preparing them, pharmaceutical compositions containing them, and immunogenic protein conjugates formed from them
IL92441A (en) Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
IL90044A0 (en) Imidazolylmethyl-cycloalkane(b)indolones,their preparation and pharmaceutical compositions containing them
NZ233255A (en) Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
EP0344211A4 (en) MONOCLONAL ANTIBODIES IN VACCINE COMPOSITIONS.